Increased midkine levels in sera from patients with Alzheimer's disease

Progress in Neuro-Psychopharmacology and Biological Psychiatry

Volumn 29, Issue 4, 2005, Pages 611-616

  Salama, Ragaa H M ^a   Muramatsu, Hisako ^a   Shimizu, Eiji ^b   Hashimoto, Kenji ^b   Ohgake, Shintaro ^b   Watanabe, Hiroyuki ^b   Komatsu, Naoya ^b   Okamura, Naoe ^b   Koike, Kaori ^b   Shinoda, Naoyuki ^b   Okada, Shin Ichi ^b   Iyo, Masaomi ^b   Muramatsu, Takashi ^a  

^a NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b CHIBA UNIVERSITY   (Japan)

Author keywords

Dementia; Neurotrophic factor; Serum marker

Indexed keywords

MIDKINE;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; BLOOD ANALYSIS; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; MALE; MINI MENTAL STATE EXAMINATION; NERVE CELL DEGENERATION; PATHOPHYSIOLOGY; PROTEIN BLOOD LEVEL; PROTEIN DETERMINATION; RANK SUM TEST; SCORING SYSTEM;

EID: 20944447216     PISSN: 02785846     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pnpbp.2005.01.018     Document Type: Article

References (36)

1. C.M. Clark, S. Xie, J. Chittams, D. Ewbank, E. Peskind, D. Galasko, J.C. Morris, D.W. McKeel Jr., M. Farlow, S.L. Weitlauf, J. Quinn, J. Kaye, D. Knopman, H. Arai, R.S. Doody, C. DeCarli, S. Leight, V.M. Lee, and J.Q. Trojanowski Cerebrospinal fluid tau and beta-amyloid: how well do these biomarkers reflect autopsy-confirmed dementia diagnoses? Arch. Neurol. 60 2003 1696 1702
2. R. Clarke, A.D. Smith, K.A. Jobst, H. Refsum, L. Sutton, and P.M. Ueland Folate, vitamin B12, and serum total homocysteine levels in confirmed Alzheimer disease Arch. Neurol. 55 1998 1449 1455
3. M.F. Folstein, S.E. Folstein, and P.R. McHugh "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician J. Psychiatr. Res. 12 1975 189 198
4. K. Fujisawa, Y. Matsumoto, H. Muramatsu, T. Shinzato, K. Hiramatsu, K. Horie, Z. Cai, H. Oka, I. Amano, T. Muramatsu, and K. Maeda Increased serum midkine levels during hemodialysis using heparin in chronic renal failure J. Biochem. (Tokyo) 123 1998 864 869
5. G.T. Grossberg Diagnosis and treatment of Alzheimer's disease J. Clin. Psychiatry 64 2003 3 6 (Suppl.)
6. B.K. Harvey, H. Shen, G.J. Chen, Y. Yoshida, and Y. Wang Midkine and retinoic acid reduce cerebral infarction induced by middle cerebral artery ligation in rats Neurosci. Lett. 369 2004 138 141
7. L. Haynes, and M. Rumsby The pleiotropin/midkine family of cytokines: role in glial-neuronal signalling Prog. Brain Res. 132 2001 313 324
8. T. Hosokawa, Y. Yamada, A. Isagoda, and R. Nakamura Psychometric equivalence of the Hasegawa Dementia Scale-Revised with the Mini-Mental State Examination in stroke patients Percept. Mot. Skills 79 1994 664 666
9. S. Ikematsu, A. Yano, K. Aridome, M. Kikuchi, H. Kumai, H. Nagano, K. Okamoto, M. Oda, S. Sakuma, T. Aikou, H. Muramatsu, K. Kadomatsu, and T. Muramatsu Serum midkine levels are increased in patients with various types of carcinomas Br. J. Cancer 83 2000 701 706
10. K.A. Johnson, K. Jones, B.L. Holman, J.A. Becker, P.A. Spiers, A. Satlin, and M.S. Albert Preclinical prediction of Alzheimer's disease using SPECT Neurology 50 1998 1563 1571
11. K. Kadomatsu, M. Tomomura, and T. Muramatsu cDNA cloning and sequencing of a new gene intensely expressed in early differentiation stages of embryonal carcinoma cells and in mid-gestation period of mouse embryogenesis Biochem. Biophys. Res. Commun. 151 1988 1312 1318
12. K. Kadomatsu, R.-P. Huang, T. Suganuma, F. Murata, and T. Muramatsu A retinoic acid responsive gene MK found in the teratocarcinoma system is expressed in spatially and temporally controlled manner during mouse embryogenesis J. Cell Biol. 110 1990 607 616
13. S. Kato, T. Shinozawa, M. Takikawa, M. Kato, A. Hirano, A. Awaya, and E. Ohama Midkine, a new neurotrophic factor, is present in glial cytoplasmic inclusions of multiple system atrophy brains Acta Neuropathol. (Berl.) 100 2000 481 489
14. K. Matsumoto, A. Wanaka, K. Takatsuji, H. Muramatsu, T. Muramatsu, and M. Tohyama A novel family of heparin-binding growth factors, pleiotrophin and midkine, is expressed in the developing rat cerebral cortex Brain Res. Dev. Brain Res. 79 1994 229 241
15. A. McCaddon, G. Davies, P. Hudson, S. Tandy, and H. Cattell Total serum homocysteine in senile dementia of Alzheimer type Int. J. Geriatr. Psychiatry 13 1998 235 239
16. G. McKhann, D. Drachman, M. Folstein, R. Katzman, D. Price, and E.M. Stadlan Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease Neurology 34 1984 939 944
17. K. Mishima, A. Asai, K. Kadomatsu, Y. Ino, K. Nomura, Y. Narita, T. Muramatsu, and T. Kirino Increased expression of midkine during the progression of human astrocytomas Neurosci. Lett. 233 1997 29 32
18. R. Mochizuki, A. Takeda, N. Sato, T. Kimpara, H. Onodera, Y. Itoyama, and T. Muramatsu Induction of midkine expression in reactive astrocytes following rat transient forebrain ischemia Exp. Neurol. 149 1998 73 78
19. A. Monji, I. Yoshida, K. Tashiro, Y. Hayashi, K. Matsuda, and N. Tashiro Inhibition of A beta fibril formation and A beta-induced cytotoxicity by senile plaque-associated proteins Neurosci. Lett. 278 2000 81 84
20. T. Muramatsu Midkine and plerotrophin: two related proteins involved in development, survival, inflammation and tumorigenesis J. Biochem. 132 2002 359 371
21. H. Muramatsu, H. Shirahama, S. Yonezawa, H. Maruta, and T. Muramatsu Midkine (MK), a retinoic acid-inducible growth/differentiation factor: immunochemical evidence for the function and distribution Dev. Biol. 159 1993 392 402
22. H. Muramatsu, X. Song, N. Koide, H. Hada, T. Tsuji, K. Kadomatsu, T. Inui, T. Kimura, S. Sakakibara, and T. Muramatsu Enzyme-linked immunoassay for midkine and its application to evaluation of midkine levels in developing mouse brain and in sera from patients with hepatocellular carcinomas J. Biochem. 119 1996 1171 1175
23. M. Nakamoto, S. Matsubara, T. Miyauchi, H. Obama, M. Ozawa, and T. Muramatsu A new family of heparin binding growth/differentiation factors: differential expression of the midkine (MK) and HB-GAM genes during mouse development J. Biochem. (Tokyo) 112 1992 346 349
24. K. Owada, N. Sanjo, T. Kobayashi, H. Mizusawa, H. Muramatsu, T. Muramatsu, and M. Michikawa Midkine inhibits caspase-dependent apoptosis via the activation of mitogen-activated protein kinase and phosphatidylinositol 3-kinase in cultured neurons J. Neurochem. 73 1999 2084 2092
25. E. Shimizu, K. Hashimoto, R.H.M. Salama, H. Watanabe, N. Komatsu, N. Okumura, K. Koike, N. Shinoda, M. Nakazato, C. Kumakiri, S. Okada, H. Muramatsu, T. Muramatsu, and M. Iyo Two clusters of serum midkine levels in drug-naive patients with schizophrenia Neurosci. Lett. 344 2003 95 98
26. X.-J. Song, H. Muramatsu, K. Aridome, T. Aikou, N. Koide, T. Tsuji, and T. Muramatsu The serum level of midkine, a heparin-binding growth factor, as a tumor marker Biomed. Res. 18 1997 375 381
27. C.E. Teunissen, J. de Vente, H.W. Steinbusch, and C. De Bruijn Biochemical markers related to Alzheimer's dementia in serum and cerebrospinal fluid Neurobiol. Aging 23 2002 485 508
28. C.E. Teunissen, D. Lutjohann, K. von Bergmann, F. Verhey, F. Vreeling, A. Wauters, E. Bosmans, H. Bosma, M.P. van Boxtel, M. Maes, J. Delanghe, H.J. Blom, M.M. Verbeek, P. Rieckmann, C. De Bruijn, H.W. Steinbusch, and J. de Vente Combination of serum markers related to several mechanisms in Alzheimer's disease Neurobiol. Aging 24 2003 893 902
29. M. Wada, M. Kamata, Y. Aizu, T. Morita, J. Hu, and K. Oyanagi Alteration of midkine expression in the ischemic brain of humans J. Neurol. Sci. 200 2002 67 73
30. O. Yasuhara, H. Muramatsu, S.U. Kim, T. Muramatsu, H. Maruta, and P.L. McGeer Midkine, a novel neurotrophic factor, is present in senile plaques of Alzheimer disease Biochem. Biophys. Res. Commun. 192 1993 246 251
31. O. Yasuhara, A. Matsuo, I. Tooyama, H. Kimura, E.G. McGeer, and P.L. McGeer Pick's disease immunohistochemistry: new alterations and Alzheimer's disease comparisons Acta Neuropathol. (Berl.) 89 1995 322 330
32. O. Yasuhara, C. Schwab, A. Matsuo, S.U. Kim, J.C. Steele, I. Akiguchi, J. Kimura, E.G. McGeer, and P.L. McGeer Midkine-like immunoreactivity in extracellular neurofibrillary tangles in brains of patients with parkinsonism-dementia complex of Guam Neurosci. Lett. 205 1996 107 110
33. Y. Yoshida, M. Goto, J. Tsutsui, M. Ozawa, E. Sato, M. Osame, and T. Muramatsu Midkine is present in the early stage of cerebral infarct Brain Res. Dev. Brain Res. 85 1 1995 25 30 (Mar 16)
34. Y. Yoshida, S. Ikematsu, T. Moritoyo, M. Goto, J. Tsutsui, S. Sakuma, M. Osame, and T. Muramatsu Intraventricular administration of the neurotrophic factor midkine ameliorates hippocampal delayed neuronal death following transient forebrain ischemia in gerbils Brain Res. 894 2001 46 55
35. G.S.P. Yu, J. Hu, and H. Nakagawa Inhibition of beta-amyloid cytotoxcity by midkine Neurosci. Lett. 254 1998 125 128
36. H. Zetterberg, L.O. Wahlund, and K. Blennow Cerebrospinal fluid markers for prediction of Alzheimer's disease Neurosci. Lett. 352 2003 67 69